Executive record

David C. Myles, Ph.D.

Chief Scientific Officer at Olema Pharmaceuticals, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:david-c-myles-ph-dVersion: public-0As of: 2026-09-30

Not yet claimed7 published Claims2 sources
  • Executive

Key Claims

Biography

Dr. Myles has served as Chief Scientific Officer since March 2026, having previously held roles at Olema since April 2008 including Chief Discovery and Non-Clinical Development Officer. Earlier in his career he co-founded Epiphany Biosciences and held roles at Kosan Biosciences, Chiron Corporation, and was an Assistant Professor at UCLA.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Scientific Officer · Olema Pharmaceuticals, Inc.
  2. 2026 to end not publishedExecutive title: Chief Scientific Officer · Organization not publishedOLMA DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. OLMA DEF 14A executive officers

    sec filing · Source published: Apr 29, 2026 · Retrieved: May 5, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Olema Pharmaceuticals, Inc. · Claim reviewed: May 5, 2026
    • Executive title: Executive title: Chief Scientific Officer · Claim reviewed: May 5, 2026
    • Other Company Role: David C. Myles, Ph.D. is also linked to Myles Business Park Owners, LLC as President. · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  2. Open source

    sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 12, 2026

    Supports 1 claim
    • Professional Role: Chief Scientific Officer at Olema Pharmaceuticals, Inc. · Claim reviewed: Sep 12, 2026